Results
1498
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1,498 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2130 | JP¥800.00 | 7.0% | -32.4% | JP¥10.2b | JP¥850.00 | PE57.3x | E37.6% | 4.0% | Media | ||
4292 | ر.س76.20 | 1.5% | 1.2% | ر.س3.2b | ر.س80.67 | PE45.3x | E21.3% | 1.4% | Consumer Services | ||
300790 | CN¥13.85 | 8.2% | 5.6% | CN¥4.5b | CN¥12.00 | PE74.1x | E32.7% | 0.7% | Tech | ||
ADZ | €4.95 | 2.7% | -18.9% | €45.7m | €6.95 | PE19.3x | E29.4% | n/a | Consumer Durables | ||
7717 | JP¥2,908.00 | 17.7% | 35.0% | JP¥28.0b | JP¥3,783.33 | PE53x | E52.3% | 2.8% | Tech | ||
BRCK | UK£0.71 | 2.0% | 32.2% | UK£227.5m | n/a | PE14.8x | E34.6% | 4.7% | Materials | ||
NOD | NOK 140.40 | 2.2% | 7.2% | NOK 27.0b | NOK 161.65 | PS5.7x | E68.2% | n/a | Semiconductors | ||
NAVA | NOK 33.00 | 10.7% | 3.1% | NOK 575.3m | NOK 45.50 | PE23.3x | E26.5% | n/a | Pharmaceuticals & Biotech | ||
TRANS | SEK 16.32 | -1.1% | -0.5% | SEK 680.4m | SEK 26.00 | PE19.1x | E59.6% | n/a | Telecom | ||
9669 | HK$3.69 | 1.9% | -49.7% | HK$2.6b | HK$7.66 | PS2.8x | E98.0% | n/a | Software |